IL-4 promotes experimental drug-induced hepatitis by reducing immune responses to haptenated proteins and inhibiting regulatory responses to native CYP2E1 (129.38)
Year: 2007
Type: conference-abstract
Source: The Journal of Immunology
Institution: Johns Hopkins University
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W195916820
